ICYMI: NEW CSRxP ANALYSIS FINDS BIG PHARMA SPENDS THREE TIMES MORE ON PROFITS, ADVERTISING AND OVERHEAD THAN R&D
Sep 9, 2026
“Big Pharma Dollar” Analysis Shows Brand Name Pharmaceutical… Read More
© 2026 CSRXP- All Rights Reserved
ICYMI
ICYMI: NEW REPORT OUTLINES MERCK’S STRATEGY TO BLOCK COMPETITION, KEEP PRICES HIGH ON BLOCKBUSTER CANCER DRUG KEYTRUDA
Apr 15, 2026
Big Pharma Giant Engages in Product Hopping Strategy to Game the Patent… Read More
ICYMI: FDA GUIDANCE PROMOTES ACCELERATED BIOSIMILAR DEVELOPMENT AND COMPETITION
Mar 11, 2026
Boosting Biosimilar Competition and Cracking Down on Big Pharma’s Egregious… Read More
ICYMI: SKINNY LABELS, BIG SAVINGS ACT INTRODUCED IN U.S. HOUSE
Dec 9, 2025
Bipartisan Solution Would Help Bring More Generics and Biosimilars to Market,… Read More
ICYMI: I-MAK SURVEY FINDS FOUR IN FIVE AMERICANS SUPPORT PATENT REFORMS TO LOWER PRESCRIPTION DRUG PRICES
Nov 11, 2025
New Findings Underscore Broad-Based Support for Market-Based Solutions to Hold… Read More
ICYMI: CSRxP SURVEY FINDS AMERICAN VOTERS OVERWHELMINGLY HOLD BIG PHARMA RESPONSIBLE FOR HIGH DRUG PRICES
Mar 6, 2025
Across Political Spectrum, Fabrizio Ward Finds Voters Identify Pharmaceutical… Read More
ICYMI: INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW ANNOUNCES ANNUAL LAUNCH PRICE AND ACCESS REPORT FOR 2025
Jan 22, 2025
New Analysis Will Help Shine a Light on Big Pharma’s Increasingly… Read More
ICYMI: AARP URGES PASSAGE OF PRESCRIPTION DRUG LEGISLATION BY YEAR’S END
Dec 13, 2024
AARP Urges Lawmakers to Pass Cornyn-Blumenthal On Friday, AARP urged lawmakers… Read More
ICYMI: SENATOR CORNYN DELIVERS REMARKS ON U.S. SENATE PASSAGE OF PATENT THICKET CRACKDOWN
Jul 15, 2024
Lawmakers Unanimously Advance Bipartisan Solution to Help Hold Big Pharma… Read More
ICYMI: CSRxP JOINS MORE THAN 50 ORGANIZATIONS CALLING ON THE U.S. SENATE TO PASS BIPARTISAN SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Nov 2, 2023
Broad-based Coalition of Advocates, Including AARP and Patients for Affordable… Read More
ICYMI: Business Insider: “Big Pharma’s Big Tax Dodge”
Aug 9, 2023
International Experts Slam Big Pharma’s Egregious Offshoring Scam of U.S. Read More
ICYMI: THE COST OF BIG PHARMA’S EGREGIOUS PATENT ABUSE ON BRAND NAME INHALERS
Jun 2, 2023
Physicians Highlight How Big Pharma Games the System to Boost Profits and… Read More